Braveheart Bio, Inc. (BRVE) Insider Trading
3 insider purchases in the last 7 days
| INSIDER | DATE | SHARES | PRICE | TOTAL VALUE | OWNED AFTER | Δ OWNED | FILING |
|---|---|---|---|---|---|---|---|
| Viehbacher Christopher Director | Aug 7, 2026 | 83,333 | $18.00 | $1.5M | 609,519 | +15.8% | |
| Forbion Growth Opportunities Fund III Cooperatief U.A. 10%+ Owner | Aug 7, 2026 | 1,920,000 | $18.00 | $34.6M | 11,640,546 | +19.8% | |
| Forbion Growth Opportunities Fund III Cooperatief U.A. 10%+ Owner | Aug 7, 2026 | 1,680,000 | $18.00 | $30.2M | 10,185,478 | +19.8% |
Want more?
Sign up free to see 30+ days of history, set alerts, and track BRVE on your watchlist.
Start for FreeAbout Braveheart Bio, Inc. Insider Trading
2 insiders at Braveheart Bio, Inc. (BRVE) have purchased stock in the past 90 days, totaling $66.3M across 3 transactions (3,683,333 shares).
The most recent purchase was by 10%+ Owner Forbion Growth Opportunities Fund III Cooperatief U.A. on August 7, 2026 — a $34.6M buy of 1,920,000 shares at $18.00, bringing his total holdings to 11,640,546 shares.
Insiders who purchased: Forbion Growth Opportunities Fund III Cooperatief U.A. (10%+ Owner, 2 buys totaling $64.8M); Viehbacher Christopher (Director, 1 buy totaling $1.5M).
This insider buying is notable given that BRVE had no recorded open market purchases in the nine months before that.
Track BRVE insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.